Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|January 1, 1993
Tumour profile of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after intraperitoneal administration in the mouseJ W Paxton, D Young, S M Evans, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenacS Zhou, J W Paxton, P Kestell, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2001
A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomideS Zhou, P Kestell, M D Tingle, et al.
Annals of Clinical Biochemistry|September 1, 1985
Direct determination of theophylline in serum by fluoroimmunoassay using highly specific antibodiesA J Hodgkinson, A M Sidki, J Landon, et al.
The Analyst|August 26, 1998
Enzyme-linked immunosorbent assay for ondansetron captured from airborne samplesD Hreczuk-Hirst, F J Rowell, R N Reeve, et al.
Cancer Chemotherapy and Pharmacology|March 11, 1999
Plasma disposition, metabolism and excretion of the experimental antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the mouse, rat and rabbitP Kestell, J W Paxton, G W Rewcastle, et al.
Placenta|May 8, 2007
Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranesI L M H Aye, J W Paxton, D A Evseenko, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1983
Serum concentration of depot neuroleptics in tardive dyskinesiaA F Fairbairn, F J Rowell, S M Hui, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell linesA C Collier, M D Tingle, J A Keelan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4 -acridinecarboxamide (CI-921) in a phase 1 trialJ W Paxton, J R Hardy, P C Evans, et al.
Pageof 11